Sign In
Buy IOVA
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
MIT Engineers Design Nanoparticles That Stimulate the Immune System to Attack Cancer Tumors
10:09am, Tuesday, 09'th Jun 2020
A Boost for Cancer Immunotherapy One promising strategy to treat cancer is stimulating the body’s own immune system to attack tumors. However, tumors are very good at suppressing the immune system,
A national registry could help defeat sepsis, a Covid-19-linked killer - STAT
08:50am, Tuesday, 09'th Jun 2020
Sepsis, the body's overreaction to an infection, contributes to many Covid-19-related deaths. A national sepsis registry could help fight this scourge.
How Peer Mentors Can Help You Succeed
12:00am, Tuesday, 09'th Jun 2020
Mentors with experience and social capital are important, but peer mentors are equally critical yet often overlooked.
Blood cancer drug shows promise in severely ill coronavirus patients
08:19pm, Monday, 08'th Jun 2020
A new study from the National Institutes of Health helped eight patients of 11 patients come off supplemental oxygen and four of eight patients come off of ventilators.
Iovance Biotherapeutics to Present at Upcoming June Conferences
08:01pm, Monday, 08'th Jun 2020
Iovance Biotherapeutics aims to improve patient care by making T cell-based immunotherapies broadly accessible for the treatment of patients with solid tumors and blood cancers. Tumor infiltrating ly
New Injection Similar to PrEP is 99% Effective at Preventing HIV Transmission
03:31am, Monday, 08'th Jun 2020
This could further decrease the alarming rate of infection in some countries around the world.
Global Nivolumab Market 2020 Industry Analysis by Key Players, Product Type, Application, Regions and Forecast to 2026
11:55am, Sunday, 07'th Jun 2020
Jun 07, 2020 (CDN Newswire via Comtex) --
The dedicated research report titled Global Nivolumab Market 2020 by Manufacturers, Regions, Type and Application,...
Drug used to treat cancer might help reduce COVID-19 severity in patients: Study
12:12pm, Saturday, 06'th Jun 2020
According to the researchers, including those from the National Cancer Institute in the US, the cancer drug acalabrutinib blocked the protein Bruton tyrosine kinase (BTK) in COVID-19 patients, and pro
Drug used to treat cancer might help reduce COVID-19 severity in patients: Study
11:50am, Saturday, 06'th Jun 2020
Scientists have observed that a drug which is already approved to treat several blood cancers, is associated with reduced respiratory distress and a reduction in the overactive immune response in COVI
Beneath the Ocean’s Surface, a Virus Is Hijacking the Most Abundant Organism on Earth
10:37am, Saturday, 06'th Jun 2020
Rice scientists analyze structure, mechanism of phage protein that steals electrons. Beneath the ocean’s surface, a virus is hijacking the metabolism of the most abundant organism on Earth. That may
You will not forget to take your Medicines anymore: A Daily Call Reminder
07:17am, Saturday, 06'th Jun 2020
A step-by-step guide with implementable code
Telemedicine Is Getting the Boost It Needs to Enter the Future
05:23pm, Friday, 05'th Jun 2020
One of your neighbors posted in Neighbor News. Click through to read what they have to say. (The views expressed in this post are the author’s own.)
BioMarker Strategies Names Greg Bertenshaw Chief Operating and Science Officer
12:00am, Friday, 05'th Jun 2020
BioMarker Strategies, LLC today announced the promotion of Greg Bertenshaw, Ph.D., to Chief Operating and Science Officer, effective immediately.
Why Is Iovance Biotherapeutics (IOVA) Down 1.4% Since Last Earnings Report?
03:31pm, Thursday, 04'th Jun 2020
Iovance Biotherapeutics (IOVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
